KR20140103939A - 흡입 프로파일-비의존적 약물 전달을 위한 에어로졸화 장치 - Google Patents

흡입 프로파일-비의존적 약물 전달을 위한 에어로졸화 장치 Download PDF

Info

Publication number
KR20140103939A
KR20140103939A KR1020147015785A KR20147015785A KR20140103939A KR 20140103939 A KR20140103939 A KR 20140103939A KR 1020147015785 A KR1020147015785 A KR 1020147015785A KR 20147015785 A KR20147015785 A KR 20147015785A KR 20140103939 A KR20140103939 A KR 20140103939A
Authority
KR
South Korea
Prior art keywords
powder
flow
outlet
opening
pharmaceutical formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020147015785A
Other languages
English (en)
Korean (ko)
Inventor
레오 찬
트리 키스 웅
제프리 위어스
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Publication of KR20140103939A publication Critical patent/KR20140103939A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0093—Inhalators mechanically breath-triggered without arming or cocking, e.g. acting directly on the delivery valve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
KR1020147015785A 2011-12-16 2012-12-14 흡입 프로파일-비의존적 약물 전달을 위한 에어로졸화 장치 Withdrawn KR20140103939A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161576768P 2011-12-16 2011-12-16
US201161576735P 2011-12-16 2011-12-16
US61/576,735 2011-12-16
US61/576,768 2011-12-16
PCT/US2012/069938 WO2013090841A2 (en) 2011-12-16 2012-12-14 Aerosolization apparatus for inhalation profile-independent drug delivery

Publications (1)

Publication Number Publication Date
KR20140103939A true KR20140103939A (ko) 2014-08-27

Family

ID=47501481

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147015785A Withdrawn KR20140103939A (ko) 2011-12-16 2012-12-14 흡입 프로파일-비의존적 약물 전달을 위한 에어로졸화 장치

Country Status (13)

Country Link
US (1) US9744318B2 (enExample)
EP (1) EP2790761B1 (enExample)
JP (1) JP2015500712A (enExample)
KR (1) KR20140103939A (enExample)
CN (1) CN103998087B (enExample)
AU (1) AU2012351947B2 (enExample)
BR (1) BR112014014399A2 (enExample)
CA (1) CA2858247A1 (enExample)
ES (1) ES2924032T3 (enExample)
IL (1) IL232762A0 (enExample)
MX (1) MX2014007277A (enExample)
RU (1) RU2615076C2 (enExample)
WO (1) WO2013090841A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8822663B2 (en) 2010-08-06 2014-09-02 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP2622064B1 (en) 2010-10-01 2019-05-29 Modernatx, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
US8710200B2 (en) 2011-03-31 2014-04-29 Moderna Therapeutics, Inc. Engineered nucleic acids encoding a modified erythropoietin and their expression
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP3492109B1 (en) 2011-10-03 2020-03-04 ModernaTX, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
HRP20220717T1 (hr) 2011-12-16 2022-07-22 Modernatx, Inc. Modificirani pripravci mrna
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
WO2013151665A2 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins associated with human disease
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US10501512B2 (en) 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
US9597380B2 (en) 2012-11-26 2017-03-21 Modernatx, Inc. Terminally modified RNA
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
AR095222A1 (es) * 2013-04-03 2015-09-30 Sanofi Sa Elemento de medición para un dispositivo de inhalación y montaje para un dispositivo de inhalación que comprende un elemento de medición
EP3024523B1 (en) 2013-07-22 2018-08-29 Inhalation Sciences Sweden AB Apparatus and method for generating an aerosol
SG11201602503TA (en) 2013-10-03 2016-04-28 Moderna Therapeutics Inc Polynucleotides encoding low density lipoprotein receptor
JP2017047130A (ja) * 2015-09-04 2017-03-09 原田車両設計株式会社 薬剤吸入装置
KR20180050320A (ko) * 2015-09-09 2018-05-14 노파르티스 아게 분무-건조된 제제의 폐로의 표적화된 전달
CN205916436U (zh) * 2016-07-13 2017-02-01 深圳市合川医疗科技有限公司 一种泡罩穿刺元件
EP3612259B1 (en) * 2017-04-17 2022-11-09 Respira Therapeutics, Inc. Unit dose dry powder inhaler
IL273553B2 (en) * 2017-10-02 2024-09-01 Novartis Ag A method for preparing a pharmacy product
CN108635643B (zh) * 2018-06-04 2025-01-10 润生药业有限公司 一种干粉吸入装置
US11864587B2 (en) * 2018-06-15 2024-01-09 Valley Product Concepts, LLC Capsules for use in personal vaporizers
WO2020135920A1 (en) * 2018-12-28 2020-07-02 Université Libre de Bruxelles Kit for inhaled chemotherapy, and treatment of lung cancer with said kit
EP3947385A1 (en) * 2019-04-04 2022-02-09 Novartis AG Siremadlin succinate
CN110286064B (zh) * 2019-08-05 2021-07-27 贵州大学 一种矿物颗粒润湿性测量装置及其测量方法
CN115089825A (zh) * 2022-07-06 2022-09-23 苏州易合医药有限公司 肺部给药装置

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
CH684746A5 (de) 1993-02-25 1994-12-15 Alusuisse Lonza Services Ag Laminat.
KR100419037B1 (ko) 1994-03-07 2004-06-12 넥타르 테라퓨틱스 폐를통한인슐린의전달방법및그조성물
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
EP0846009B1 (en) * 1994-09-21 2008-03-05 Nektar Therapeutics Apparatus and method for dispersing dry powder medicaments
US5693609A (en) 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
JP3708553B2 (ja) 1995-04-14 2005-10-19 ネクター セラピューティクス 向上した分散性を有する粉末型薬理組成物
US6258341B1 (en) 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6270869B1 (en) 1998-12-02 2001-08-07 Alusuisse Technology & Management Ltd. Cold formable laminate films
US6606992B1 (en) 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations
DK1666028T3 (da) 1999-10-29 2010-06-21 Novartis Ag Tørre pulversammensætninger med forbedret dispersitet
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US6668827B2 (en) * 2000-05-16 2003-12-30 Nektar Therapeutics Systems devices and methods for opening receptacles having a powder to be fluidized
SE0101825D0 (sv) * 2001-05-22 2001-05-22 Astrazeneca Ab An Inhalation device
GB0315509D0 (en) * 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
GB2405798A (en) * 2003-09-15 2005-03-16 Vectura Ltd Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device.
GB0427856D0 (en) * 2004-12-20 2005-01-19 Glaxo Group Ltd Maniflod for use in medicament dispenser
BRPI0718315A2 (pt) 2006-10-25 2013-11-12 Novartis Ag Aparelho e dispersão de pó, método de fabricação e utilização do aparelho, e componentes que possam ser usados no aparelho e em outros dispositivos.
EP2082764A1 (en) * 2008-01-24 2009-07-29 Boehringer Ingelheim International GmbH Inhaler
CA2724009C (en) * 2008-05-15 2016-10-11 Novartis Ag Pulmonary delivery of a fluoroquinolone
CA3086027C (en) * 2008-06-13 2022-05-17 Mannkind Corporation A dry powder inhaler and system for drug delivery
WO2010039200A2 (en) 2008-09-30 2010-04-08 Oriel Therapeutics, Inc. Dry powder inhalers with endless strips and cooperating piercers and related methods

Also Published As

Publication number Publication date
AU2012351947A1 (en) 2014-06-26
US9744318B2 (en) 2017-08-29
ES2924032T3 (es) 2022-10-04
CN103998087B (zh) 2017-04-05
WO2013090841A2 (en) 2013-06-20
EP2790761B1 (en) 2022-05-11
CA2858247A1 (en) 2013-06-20
EP2790761A2 (en) 2014-10-22
JP2015500712A (ja) 2015-01-08
RU2014128828A (ru) 2016-02-10
BR112014014399A2 (pt) 2017-06-13
MX2014007277A (es) 2014-07-28
CN103998087A (zh) 2014-08-20
US20140318539A1 (en) 2014-10-30
WO2013090841A3 (en) 2013-08-08
RU2615076C2 (ru) 2017-04-03
AU2012351947B2 (en) 2017-08-17
IL232762A0 (en) 2014-07-31

Similar Documents

Publication Publication Date Title
RU2615076C2 (ru) Устройство аэрозолизации для независимой от профиля вдоха доставки лекарственного средства
KR100652532B1 (ko) 유동 저항이 조절된 에어로졸화 활성 약물의 송달
JP4542090B2 (ja) カプセル穿刺整合ガイドを有するエアロゾル化装置
JP6348501B2 (ja) 超低密度肺粉剤
JP6312262B2 (ja) 乾燥粉末薬物送達システム
JP2006527046A (ja) 粉末エアロゾル用送給装置
KR20050114720A (ko) 공기 입구 차폐 부재를 갖춘 에어로졸화 장치
JP2007530671A (ja) 事前計量されるｄｐｉのための乾燥粉末調合剤
CN115919780A (zh) 含有硬脂酸镁的干粉组合物
KR20200105857A (ko) 폐 투여에 의한 우울증의 치료에 사용하기 위한 건조 분말 케타민 조성물
KR20210117265A (ko) 건조 분말 흡입기 장치
MXPA06014502A (es) Reduccion de retencion de polvo en superficies.
KR20200115560A (ko) 흡입형 치료제의 고용량 전달
JP4266399B2 (ja) 粉末状吸入用医薬品組成物
CN113038941A (zh) 用于通过肺部施用治疗抑郁症的方法中的氯胺酮组合物
D’Lima Characterization of a Novel Dry Powder Inhaler
HK1116391A (en) Minimizing powder retention on surfaces

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140611

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid